CN102435693B - Method for controlling quality of midbody during preparation process of Shenmai injection - Google Patents

Method for controlling quality of midbody during preparation process of Shenmai injection Download PDF

Info

Publication number
CN102435693B
CN102435693B CN 201110455674 CN201110455674A CN102435693B CN 102435693 B CN102435693 B CN 102435693B CN 201110455674 CN201110455674 CN 201110455674 CN 201110455674 A CN201110455674 A CN 201110455674A CN 102435693 B CN102435693 B CN 102435693B
Authority
CN
China
Prior art keywords
alcohol extract
red ginseng
ginsenoside
tuber
dwarf lilyturf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201110455674
Other languages
Chinese (zh)
Other versions
CN102435693A (en
Inventor
刘娅
毛洁
詹祥静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHUANDA HUAXI PHARMACEUTICAL INDUSTRY Co Ltd SICHUAN PROV
Original Assignee
CHUANDA HUAXI PHARMACEUTICAL INDUSTRY Co Ltd SICHUAN PROV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHUANDA HUAXI PHARMACEUTICAL INDUSTRY Co Ltd SICHUAN PROV filed Critical CHUANDA HUAXI PHARMACEUTICAL INDUSTRY Co Ltd SICHUAN PROV
Priority to CN 201110455674 priority Critical patent/CN102435693B/en
Publication of CN102435693A publication Critical patent/CN102435693A/en
Application granted granted Critical
Publication of CN102435693B publication Critical patent/CN102435693B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a method for controlling the quality of a midbody during a preparation process of a Shenmai injection. The midbody during the preparation process of the Shenmai injection comprises a red ginseng alcohol extract, a red ginseng refined filtrate, a radix ophiopogonis alcohol extract and a radix ophiopogonis refined filtrate, wherein the total weight percent of the solid in the red ginseng alcohol extract is 10.0%-27.0%; counted by the weight of crude drugs, the red ginseng alcohol extract contains 1.06-2.53mg/g of ginsenoside Rg1(C42H72O14) and 0.66-1.42mg/g of ginsenoside Re(C48H82O18); the total weight percent of the solid in the red ginseng refined filtrate is 8.0%-23.0%; counted by the weight of crude drugs, the red ginseng refined filtrate contains 1.06-2.53mg/g of ginsenoside Rg1(C42H72O14) and 0.66-1.42mg/g of ginsenoside Re(C48H82O18); the total weight percent of the solid in the radix ophiopogonis alcohol extract is 8.0%-19.0%; counted by the weight of a dry product and counted by the weight of radix ophiopogonis saponin D(C44H70O16), the total content of the saponin in the radix ophiopogonis alcohol extract is not less than 1.0%; and the total weight percent of the solid in the radix ophiopogonis refined filtrate is 8.0%-19.0%. A purpose of fully controlling the quality of an end product is achieved by controlling the quality of the midbody during the preparation process of the Shenmai injection.

Description

A kind of method of controlling the intermediate quality in the Shenmai injection preparation process
Technical field
The present invention relates to a kind of method of controlling the intermediate quality in the Shenmai injection preparation process.
Background technology
Shenmai injection is mainly used in supplementing QI to prevent collapse, and nourishing Yin and promoting production of body fluid is given birth to arteries and veins.The shock, coronary heart disease, vital myocarditis, chronic cardiopulmonary disease, the agranulocytosis that are used for the treatment of type of deficiency of both QI and YIN.Can improve the immunity function of tumour patient, when share with chemotherapeutics, certain synergistic effect be arranged, and can reduce the caused toxicity of chemotherapeutics.Composition: red ginseng, the tuber of dwarf lilyturf.Auxiliary material is polyoxyethylene sorbitan monoleate, sodium bisulfite.
Proterties: this product is that little yellow is to amber clear liquid.Usage and dosage: intramuscular injection, a 2-4ml, 1 time on the one.Drip-feed, 20-100ml (with using after the 5% glucose injection 250-500ml dilution) or follow the doctor's advice.The national drug standards: WS3-B-3428-98-2010Z.The quality standard of only having finished product in the drug standards can't guarantee the quality control in the preparation process.
Summary of the invention
Technical scheme of the present invention has provided a kind of method of controlling the intermediate quality in the Shenmai injection preparation process.
The invention provides a kind of method of controlling the intermediate quality in the Shenmai injection preparation process, the intermediate in the described Shenmai injection preparation process comprises smart filtrate of the smart filtrate of red ginseng alcohol extract, red ginseng, tuber of dwarf lilyturf alcohol extract, the tuber of dwarf lilyturf; Alcohol extract is as the product of First operation in the technique, and its quality control is particularly crucial; Last procedure before smart filtrate is mixed with as parenteral solution can either be verified the stability that alcohol extract is controlled, and also can further ensure end product quality.
The total solid percentage composition is 10.0%-27.0% in the red ginseng alcohol extract; The red ginseng alcohol extract contains the ginsenoside Rg by the crude drug amount 1(C 42H 72O 14) should be 1.06-2.53mg/g, ginsenoside Re (C 48H 82O 18) should be 0.66-1.42mg/g; The smart filtrate total solid of red ginseng percentage composition is 8.0%-23.0%; The smart filtrate this product of red ginseng contains the ginsenoside Rg by the crude drug amount 1(C 42H 72O 14) 1.06-2.53mg/g, ginsenoside Re (C 48H 82O 18) should be 0.66-1.42mg/g;
The tuber of dwarf lilyturf, alcohol extract total solid percentage composition was 8.0%-19.0%; The tuber of dwarf lilyturf, the alcohol extract total saponin content calculated with dry product, with ophiopogonin D (C 44H 70O 16) meter, be not less than 1.0%; The tuber of dwarf lilyturf, smart filtrate total solid percentage composition was 8.0%-19.0%.
Wherein, the chromatographic condition of described red ginseng alcohol extract finger-print and assay is: chromatographic column: Waters symmetryshield TMRP 18(4.6mm * 250mm; 5.0 μ m); Column temperature: 30 ℃; Detect wavelength: 203nm; Mobile phase: acetonitrile-water, according to the form below carries out gradient elution; Number of theoretical plate is pressed ginsenoside Rb 1The peak calculates should be not less than 2000000:
Figure BDA0000127404040000021
The preparation of object of reference solution: precision takes by weighing through ginsenoside Rb 1Reference substance is an amount of, adds 5% methyl alcohol and makes the solution that every 1ml contains 0.2mg, and get final product; The preparation of need testing solution: getting this product, an amount of (about 4~6ml), evaporate to dryness in water-bath, residue add water makes dissolving, put in the 10ml measuring bottle, thin up shakes up to scale (being equivalent to approximately medicinal material 0.1mg/ml), filter with 0.45 μ m miillpore filter, get filtrate, and get final product; Determination method: precision is drawn object of reference solution and each 10 μ l of need testing solution respectively, and the injection liquid chromatography is measured.
Described tuber of dwarf lilyturf, the alcohol extract content assaying method was:
Color condition: take perchloric acid as developer;
Reference substance solution: precision takes by weighing ophiopogonin D 5mg, places the 25ml measuring bottle, with methyl alcohol dissolving and be settled to 25ml, and get final product;
The preparation of typical curve: precision is measured reference substance solution 0.1,0.3,0.5,1.0,1.5,2.0ml and is placed respectively the dry tool plug of 10ml test tube, volatilize solvent, the accurate perchloric acid 10ml that adds, reaction is 15 minutes in 65 ℃ of water-baths, cools off with ice-water bath, the retinue solvent is blank, according to UV-VIS spectrophotometry (Chinese Pharmacopoeia version appendix in 2005 V A), measure absorption value in 396nm, take absorption value as ordinate, concentration is horizontal ordinate, the drawing standard curve;
Determination method: precision is measured need testing solution 0.5ml, puts the dry tool plug of 10ml test tube, and method under the sighting target directrix curve item from " volatilizing solvent ", is measured absorbance in accordance with the law, from the amount that typical curve is read ophiopogonin D the need testing solution, calculates, and get final product.
By the quality of the intermediate in the control Shenmai injection preparation process, reach the purpose of comprehensive control finished product quality.
Description of drawings
Fig. 1 joins wheat extract preparation technology process flow diagram and sees
The test sample finger-print of Fig. 2 red ginseng alcohol extract
Fig. 3 red ginseng alcohol extract withinday precision is investigated the result
The result is investigated in the test of Fig. 4 reappearance
Embodiment
Ginseng wheat extract preparation technology process flow diagram is seen Fig. 1
Table 1 injection containing ginseng extract liquid preparing process of the present invention critical process and parameter control criterion
Figure BDA0000127404040000031
The ginseng ginseng is extracted quality of intermediate amount standard in embodiment 1 Shenmai injection of the present invention
Table 2 red ginseng extracts quality of intermediate amount control project
Figure BDA0000127404040000041
One, the quality standard of red ginseng alcohol extract
A. proterties this product is yellow to the yellowish-brown clear liquid
The measurement result of table 3 proterties
The sample lot number Color proterties (n=3) Clarity (n=3)
091114-CT Yellow Clarification is without muddy
091210-CT Yellow Clarification is without muddy
091211-CT Yellow Clarification is without muddy
According to the above results, set the proterties of this product.Consider visual inspection, be set as and be yellow to yellowish-brown.
B. the total solid precision is got this product 10ml and is put in the constant weight evaporating dish, behind evaporate to dryness in the water-bath 105 ℃ of dryings 3 hours to constant weight, the total cooling of dislocation exsiccator 30 minutes, weighed weight, calculate the content of solid content, and be converted into the percentage composition of weight (mg/g) according to the crude drug amount.The results are shown in Table 4.
Table 4 red ginseng alcohol extract total solids content measured value (%)
Figure BDA0000127404040000042
With each batch measured value ± 20% upper and lower limit that settles the standard, working out limit is 10.0%-27.0%.After having accumulated aborning more data from now on, revise again more suitably limit.
C. finger-print
This test is mainly done the precision that detects and reappearance and is checked, and sets up red ginseng alcohol extract internal control finger-print standard.
C.1 instrument and reagent
Agilent 1100 series of high efficiency liquid chromatographs (Chemstation chromatographic work station), Mettler AE240 electronic balance, acetonitrile and methyl alcohol are chromatographically pure, and water is double distilled water, and it is pure that all the other reagent are analysis.
C.2 chromatographic condition:
Chromatographic column: Waters symmetryshield TMRP 18(4.6mm * 250mm; 5.0 μ m);
Column temperature: 30 ℃
Detect wavelength: 203nm
Mobile phase: acetonitrile-water, according to the form below carries out gradient elution; Number of theoretical plate is pressed ginsenoside Rb 1The peak calculates should be not less than 2000000.
Figure BDA0000127404040000051
Integral parameter: Slope Sensitivity:5, peak width:0.05, smallest peaks area are 10% of S peak-to-peak area; Minimum peak height be the S peak-to-peak high 10%, the baseline integration, limit of integration is 5~105 minutes.
The preparation of object of reference solution: precision takes by weighing through ginsenoside Rb 1Reference substance is an amount of, adds 5% methyl alcohol and makes the solution that every 1ml contains 0.2mg, and get final product.
The preparation of need testing solution: getting this product, an amount of (about 4~6ml), evaporate to dryness in water-bath, residue add water makes dissolving, put in the 10ml measuring bottle, thin up shakes up to scale (being equivalent to approximately medicinal material 0.1mg/ml), filter with 0.45 μ m miillpore filter, get filtrate, and get final product.
Determination method: precision is drawn object of reference solution and each 10 μ l of need testing solution respectively, and the injection liquid chromatography is measured.(seeing Fig. 2)
C.3 precision test is got red ginseng alcohol extract (lot number: 091210-CT) make need testing solution, draw respectively each 10 μ l injection liquid chromatography of reference substance and need testing solution, measure by above-mentioned chromatographic condition, and get final product.Test sample continuous sample introduction 5 pins wherein.Select first 16 chromatographic peaks as total chromatographic peak, calculate relative peak area, see Table 5, Fig. 3:
Figure BDA0000127404040000061
Therefore the RSD value of relative peak area less than 3.0%, illustrates that the withinday precision test findings of red ginseng alcohol extract finger-print is good 0.22%~2.63%.
C.4 the reappearance test is got red ginseng alcohol and is got extract (lot number: 091210) 4.5ml, 5 parts of the same form, respectively at evaporate to dryness in the water-bath, residue adds water makes dissolving, puts in the 10ml measuring bottle, thin up is to scale, shake up, filter with 0.45 μ m miillpore filter, get filtrate 10 μ l injection liquid chromatographies, measure by above-mentioned chromatographic condition, and get final product.Select first 15 chromatographic peaks as total chromatographic peak, calculate relative peak area, see Table 6, Fig. 4:
Figure BDA0000127404040000062
Therefore the RSD value of relative peak area less than 3.0%, illustrates that the withinday precision test findings of red ginseng alcohol extract finger-print is good 0.18%~2.65%.
C.5 red ginseng alcohol extract standard control finger-print inner quality standard is set up
This product finger-print as calculated machine simulation similarity software (similarity evaluation version in 2004) B version calculates
D. assay
The preparation of instrument and reagent, chromatographic condition, need testing solution is same C.1, C.2, and theoretical cam curve is calculated by the ginsenoside Re should be not less than 300000, the ginsenoside Rg 1Must not be lower than 1.8. with the degree of separation of Re
The preparation of reference substance solution: precision takes by weighing the ginsenoside Rg 1An amount of with the Re reference substance, add 5% methyl alcohol and make the solution that every 1ml contains respectively 0.1mg and 0.08mg.
D.1 precision test
Adopt a D.3 lower method mensuration, wherein need testing solution continuous sample introduction 6 pins calculate the ginsenoside Rg 1Content with Re.Experimental result sees Table 7.
Table 7 Precision test result
Figure BDA0000127404040000071
Result: ginsenoside Rg 1Peak area RSD%=0.56%, ginsenoside Re's peak area RSD%=0.96% all less than 1.5%, shows that this content assaying method precision is good.
D.2 reappearance test
Adopt a C.4 lower method mensuration, get respectively reference substance solution and need testing solution sample introduction and measure, calculate the ginsenoside Rg 1Content with Re.Experimental result sees Table 8.
Table 8 reproducible test results
Figure BDA0000127404040000072
Result: ginsenoside Rg 1Peak area RSD%=0.10%, ginsenoside Re's peak area RSD%=0.74% all less than 1.5%, shows that this content assaying method reappearance is good.
D.3 red ginseng alcohol extract sample determination
Measure ginsenoside Rg in 3 batches of red ginseng alcohol extracts 1With ginsenoside Re's content, and press the crude drug amount and convert the ginsenoside Rg 1Content range is at 1.37~2.11mg/g, and ginsenoside Re's content range is at 0.83~1.18mg/g.Consider the diversity of crude drug source, by minimum mxm. ± 20% determine the content bound, determine that this product by the crude drug amount, contains the ginsenoside Rg 1(C 42H 72O 14) should be 1.06-2.53mg/g, ginsenoside Re (C 48H 82O 18) should be 0.66-1.42mg/g.The results are shown in Table 9.
Table 9 red ginseng alcohol extract sample determination result
The sample lot number The ginsenoside Rg1 The ginsenoside Re
091114-CT 2.11 1.18
091210-CT 1.37 0.83
091211-CT 1.39 0.88
Mean value 1.62 0.96
Two, the smart filtrate standard of red ginseng
A, proterties this product are yellow to the yellowish-brown clear liquid
The measurement result of proterties
The sample lot number Color proterties (n=3) Clarity (n=3)
091114-J Yellow Clarification is without muddy
091210-J-1 Yellow Clarification is without muddy
091210-J-2 Yellow Clarification is without muddy
091211-J-1 Yellow Clarification is without muddy
091211-J-2 Yellow Clarification is without muddy
According to the above results, set the proterties of this product.Consider visual inspection, be set as and be yellow to yellowish-brown.
B, pH value
B.1 instrument: PHS-3C acidometer
B.2 measurement result:
The smart filtrate pH of table 10 red ginseng pH-value determination pH result
Figure BDA0000127404040000081
According to measurement result, determine that the pH value should be 6.5~8.5.
C, total solid precision are got this product 10ml and are put in the constant weight evaporating dish, behind evaporate to dryness in the water-bath 105 ℃ of dryings 3 hours to constant weight, the total cooling of dislocation exsiccator 30 minutes, weighed weight, calculate the content of solid content, and be converted into the percentage composition of weight according to the crude drug amount.The results are shown in Table 11.
The smart filtrate total solids content measured value (%) of table 11 red ginseng
Figure BDA0000127404040000091
By actual measurement sample minimum mxm. ± 20% determine the total solid bound, working out limit is 8.0%-23.0%.Accumulated aborning from now on after many data, revised again more suitably limit.
D. finger-print
Adopt red ginseng alcohol extract fingerprint spectrum method, see red ginseng alcohol extract inner quality standard for details.
D.1 the smart filtrate standard control of red ginseng finger-print inner quality standard is set up
This product finger-print as calculated machine simulation similarity software (similarity evaluation version in 2004) B version calculates.
E, assay
E.1 adopt red ginseng alcohol extract content assaying method, see red ginseng alcohol extract standard for details.
E.2 C.1 instrument and reagent, chromatographic condition draft, C.2 with red ginseng alcohol extract standard, and theoretical cam curve is calculated by the ginsenoside Re should be not less than 300000, the ginsenoside Rg 1Must not be lower than 1.8 with the degree of separation of Re.
The preparation of need testing solution: getting this product, an amount of (about 1.5~3ml), evaporate to dryness in water-bath, residue add water makes dissolving, put in the 10ml measuring bottle, thin up shakes up to scale (being equivalent to approximately medicinal material 0.1mg/ml), filter with 0.45 μ m miillpore filter, get filtrate, and get final product.
The preparation of reference substance solution: precision takes by weighing the ginsenoside Rg 1An amount of with the Re reference substance, add 5% methyl alcohol and make the solution that every 1ml contains respectively 0.1mg and 0.08mg.
E.3 the smart filtrate sample of red ginseng is measured
Measure ginsenoside Rg in the smart filtrate of 5 batches of red ginsengs 1With ginsenoside Re's content, and press the crude drug amount and convert the ginsenoside Rg 1Content range is at 1.36-2.05mg/g, and ginsenoside Re's content range is at 0.84-1.15mg/g.Consider the diversity of crude drug source, determine that this product by the crude drug amount, contains the ginsenoside Rg 1(C 42H 72O 14) 1.06-2.53mg/g, ginsenoside Re (C 48H 82O 18) should be 0.66-1.42mg/g.The results are shown in Table 12.
The smart filtrate sample measurement result of table 12 red ginseng
The sample lot number The ginsenoside Rg1 The ginsenoside Re
091114-J 2.05 1.15
091210-J-1 1.41 0.84
091210-J-2 1.74 1.05
091211-J-1 1.36 0.84
091211-J-2 1.45 0.89
Mean value 1.60 0.95
Embodiment 2 Shenmai injection ophiopogon japonicus extract quality standards of the present invention
Table 13 extracts quality of intermediate amount control project the tuber of dwarf lilyturf
Figure BDA0000127404040000101
One, the tuber of dwarf lilyturf, the alcohol extract standard was drafted explanation
A, proterties this product are that little yellow refers to yellow clear liquid.
The measurement result of table 14 proterties
The sample lot number Color proterties (n=3) Clarity (n=3)
C091101CT Little yellow Clarification
091204CT Little yellow Clarification
According to the above results, set the proterties of this product.Consider visual inspection, be set as and be little yellow~yellow.
B, total solid precision are got this product 10ml and are put in the constant weight evaporating dish, behind evaporate to dryness in the water-bath 105 ℃ of dryings 3 hours to constant weight, the total cooling of dislocation exsiccator 30 minutes, weighed weight, calculate the content of solid content, and be converted into the percentage composition of mg/g according to the crude drug amount.The results are shown in Table 15.
Table 15 alcohol extract tuber of dwarf lilyturf total solids content measured value (%)
Figure BDA0000127404040000102
Working out limit is 8.0%-19.0%.
C, assay
Be the control extraction quality of the tuber of dwarf lilyturf, we are chosen in tuber of dwarf lilyturf alcohol extract and measure its total saponin content.Total saponin(e assay method specificity of recording in the Shenmai injection finished product standard is relatively poor, and precision and the reappearance of sample determination are bad.The present invention has set up take ophiopogonin D as reference substance, the content method of the total saponin(e of the determined by ultraviolet spectrophotometry alcohol extract tuber of dwarf lilyturf.
C.1 instrument and reagent
Shimadzu UV-2100 ultraviolet spectrophotometer (Shimadzu Corp), the Mettler electronic balance.Ophiopogonin D reference substance (the Chengdu Cisco China HPLC of Bioisystech Co., Ltd 〉=98.0%), perchloric acid, anhydrous dextrose, methyl alcohol are that analysis is pure, experimental water is purified water.
C.2 color condition is take perchloric acid as developer
C.3 the selection of absorbing wavelength
C.4 the reference substance solution precision takes by weighing ophiopogonin D 5mg, places the 25ml measuring bottle, with methyl alcohol dissolving and be settled to 25ml, and get final product.
C.5 the preparation of typical curve
Precision is measured reference substance solution 0.1,0.3,0.5,1.0,1.5,2.0ml and is placed respectively the dry tool plug of 10ml test tube, volatilize solvent, the accurate perchloric acid 10ml that adds, reaction is 15 minutes in 65 ℃ of water-baths, cools off with ice-water bath, the retinue solvent is blank, according to UV-VIS spectrophotometry (Chinese Pharmacopoeia version appendix in 2005 V A), measure absorption value in 396nm, take absorption value as ordinate, concentration is horizontal ordinate, the drawing standard curve.
The determination method precision is measured need testing solution 0.5ml, puts the dry tool plug of 10ml test tube, and method under the sighting target directrix curve item from " volatilizing solvent ", is measured absorbance in accordance with the law, from the amount that typical curve is read ophiopogonin D the need testing solution, calculates, and get final product.
C.6 application of sample recovery experiment precision is measured alcohol extracting tuber of dwarf lilyturf need testing solution (C091101-CT) 0.5ml, puts the dry tool plug of 10ml test tube, and totally 9 parts, precision adds ophiopogonin D reference substance solution 0.2,0.5,1.0ml respectively again, each three parts of each concentration; Retinue get with batch tuber of dwarf lilyturf alcohol extract 0.5ml compare.Method under the sighting target directrix curve item from " volatilizing solvent ", is measured absorbance in accordance with the law, reads the amount that application of sample reclaims ophiopogonin D each sample from typical curve, tries to achieve the ophiopogonin D recovery, the results are shown in Table 16.
Table 16 alcohol extract tuber of dwarf lilyturf assay application of sample recovery experiment result
Figure BDA0000127404040000121
The application of sample recovery test is the result show: because of spectrophotometric method method limitation, accuracy is not high enough, and average recovery rate is 91.3%, but variation is less, and the recovery of high, medium and low concentration is all more stable, the reference method of the content control of product in the middle of therefore can be used as.
C.7 reappearance test precision is got alcohol extracting tuber of dwarf lilyturf need testing solution (C091101-CT) 0.5ml, totally 5 parts, put the dry tool plug of 10ml test tube, method under the sighting target directrix curve item, from " volatilizing solvent ", measure absorbance in accordance with the law, from the amount that typical curve is read ophiopogonin D the need testing solution, calculate total saponin content and RSD value in the alcohol extract tuber of dwarf lilyturf.(seeing Table 17)
Table 17 alcohol extract tuber of dwarf lilyturf total saponin content assay method reproducible test results
The method reappearance is good.
C.8 arbitrary duplicate samples in the reappearance test is got in stability test, and timing after finishing with chromogenic reaction is measured absorption value in 396nm, records 0,30,60,90,120,180 minute absorption value (seeing Table 18)
Table 18 content assaying method tuber of dwarf lilyturf stability test result
As seen: after the tuber of dwarf lilyturf, the herbal extract chromogenic reaction stopped, should in 60 minutes, measure absorbance log.
C.9 the many batches of alcohol extract total saponin content measurement results tuber of dwarf lilyturf (seeing Table 19)
Table 19 different batches alcohol extract tuber of dwarf lilyturf assay result
Lot number Total saponin content (g/g)
C091101CT 1.52%
091204CT 1.51%
Just build because of alcohol extracting tuber of dwarf lilyturf total saponin content assay method, data accumulation is few, thus determine the inner quality standard lower limit with-30% of mean value, wouldn't capping.Be the tuber of dwarf lilyturf alcohol extract total saponin content calculate with dry product, with ophiopogonin D (C 44H 70O 16) meter, be not less than 1.0%.
Two, the tuber of dwarf lilyturf, smart filtrate standard was drafted explanation
A, the little yellow of proterties this product refer to yellow clear liquid.
The measurement result of table 20 proterties
The sample lot number Color proterties (n=3) Clarity (n=3)
C091101-1-J Little yellow Clarification
C091101-2-J-1 Little yellow Clarification
C091101-2-J-2 Little yellow Clarification
091204-J-1 Little yellow Clarification
091204-J-2 Little yellow Clarification
B, pH value
B.1 instrument: PHS-3C acidometer
B.2 measurement result:
Table 21 smart filtrate pH tuber of dwarf lilyturf pH-value determination pH result
Figure BDA0000127404040000131
According to measurement result, determine that the pH value should be 6.0~7.0
C, total solid precision are got this product 10ml and are put in the constant weight evaporating dish, behind evaporate to dryness in the water-bath 105 ℃ of dryings 3 hours to constant weight, the total cooling of dislocation exsiccator 30 minutes, weighed weight, calculate the content of solid content, and be converted into the percentage composition of weight (mg/g) according to the crude drug amount.The results are shown in Table 22.
Table 22 smart filtrate total solids content measured value (%) tuber of dwarf lilyturf
Figure BDA0000127404040000132
Working out limit is 8.0%-19.0%, accumulated aborning more data from now on after, revise again more suitably limit.
For guaranteeing the stable of production run, because may there be certain error in metering method, intermediate has been stipulated following normal fluctuation range simultaneously in addition.(take every crowd of dosing amount 1200L as example)
Table 23 red ginseng intermediate volume term of reference and crude drug content
Figure BDA0000127404040000141
Table 24 intermediate tuber of dwarf lilyturf volume term of reference and crude drug content
Figure BDA0000127404040000142
Table 25 Quality control of intermediates project
Figure BDA0000127404040000143

Claims (1)

1. method that detects the intermediate quality in the Shenmai injection preparation process is characterized in that: the intermediate in the described Shenmai injection preparation process comprises smart filtrate of red ginseng alcohol extract, the smart filtrate of red ginseng, tuber of dwarf lilyturf alcohol extract, the tuber of dwarf lilyturf;
The total solid percentage composition is 10.0%-27.0% in the red ginseng alcohol extract; The red ginseng alcohol extract contains the ginsenoside Rg by the crude drug amount 1C 42H 72O 14Should be 1.06-2.53 mg/g, ginsenoside Re C 48H 82O 18Should be 0.66-1.42 mg/g; The smart filtrate total solid of red ginseng percentage composition is 8.0%-23.0%; The smart filtrate this product of red ginseng contains the ginsenoside Rg by the crude drug amount 1C 42H 72O 141.06-2.53 mg/g, ginsenoside Re C 48H 82O 18Should be 0.66-1.42 mg/g;
The tuber of dwarf lilyturf, alcohol extract total solid percentage composition was 8.0%-19.0%; The tuber of dwarf lilyturf, the alcohol extract total saponin content calculated with dry product, with ophiopogonin D C 44H 70O 16Meter is not less than 1.0%; The tuber of dwarf lilyturf, smart filtrate total solid percentage composition was 8.0%-19.0%;
Wherein, the chromatographic condition of red ginseng alcohol extract finger-print and assay is:
Chromatographic column: Waters symmetryshield TMRP 184.6mm * 250mm; 5.0 μ m; Column temperature: 30 ℃; Detect wavelength: 203nm; Mobile phase: acetonitrile-water, according to the form below carries out gradient elution; Number of theoretical plate is pressed ginsenoside Rb 1The peak calculates should be not less than 2000000:
Figure 2011104556747100001DEST_PATH_IMAGE001
The preparation of object of reference solution: precision takes by weighing through ginsenoside Rb 1Reference substance is an amount of, adds 5% methyl alcohol and makes the solution that every 1ml contains 0.2mg, and get final product; The preparation of need testing solution: get this product 4~6ml, evaporate to dryness in water-bath, residue add water makes dissolving, puts in the 10ml measuring bottle, and thin up is equivalent to medicinal material 0.1mg/ml to scale, shakes up, and filters with 0.45 μ m miillpore filter, gets filtrate, and get final product; Determination method: precision is drawn object of reference solution and each 10 μ l of need testing solution respectively, and the injection liquid chromatography is measured;
Described tuber of dwarf lilyturf, the alcohol extract content assaying method was:
Color condition: take perchloric acid as developer;
Reference substance solution: precision takes by weighing ophiopogonin D 5mg, places 25 ml measuring bottles, with methyl alcohol dissolving and be settled to 25 ml, and get final product;
The preparation of typical curve: precision is measured reference substance solution 0.1,0.3,0.5,1.0,1.5,2.0 ml place respectively the dry tool plug of 10 ml test tube, volatilize solvent, the accurate perchloric acid 10ml that adds, reaction is 15 minutes in 65 ℃ of water-baths, cools off with ice-water bath, the retinue solvent is blank, according to the described UV-VIS spectrophotometry of Chinese Pharmacopoeia version appendix in 2005 V A, measure absorption value in 396nm, take absorption value as ordinate, concentration is horizontal ordinate, the drawing standard curve;
Determination method: precision is measured need testing solution 0.5 ml, puts the dry tool plug of 10 ml test tube, and method under the sighting target directrix curve item from " volatilizing solvent ", is measured absorbance in accordance with the law, from the amount that typical curve is read ophiopogonin D the need testing solution, calculates, and get final product.
CN 201110455674 2011-12-30 2011-12-30 Method for controlling quality of midbody during preparation process of Shenmai injection Active CN102435693B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110455674 CN102435693B (en) 2011-12-30 2011-12-30 Method for controlling quality of midbody during preparation process of Shenmai injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110455674 CN102435693B (en) 2011-12-30 2011-12-30 Method for controlling quality of midbody during preparation process of Shenmai injection

Publications (2)

Publication Number Publication Date
CN102435693A CN102435693A (en) 2012-05-02
CN102435693B true CN102435693B (en) 2013-03-27

Family

ID=45983858

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110455674 Active CN102435693B (en) 2011-12-30 2011-12-30 Method for controlling quality of midbody during preparation process of Shenmai injection

Country Status (1)

Country Link
CN (1) CN102435693B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015042852A1 (en) * 2013-09-27 2015-04-02 四川川大华西药业股份有限公司 Method for detecting pulse-activating injection intermediates
CN103728332B (en) * 2014-01-24 2016-08-17 西南民族大学 A kind of discrimination method of Shenmai injection end product quality
CN104713978A (en) * 2015-01-28 2015-06-17 神威药业集团有限公司 Method for quantitatively detecting saponin components in Radix Ginseng Rubra and Radix Ophiopogonis injection
CN109212121A (en) * 2018-09-10 2019-01-15 华润三九(雅安)药业有限公司 Red ginseng medicinal materials fingerprint and its construction method with formulation ingredients relevance

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
制备工艺对参麦注射液质量的影响;吴永江;《中国中药杂志》;20050531;第30卷(第9期);第662-665页 *
卫生部药典委员会编.参麦注射液.《卫生部颁药品标准(中药成方制剂第十八册)》.1997,全文. *
吴永江.制备工艺对参麦注射液质量的影响.《中国中药杂志》.2005,第30卷(第9期),第662-665页.
石先哲等.色谱指纹图谱法在参麦注射液质控中的应用.《色谱》.2002,第20卷(第4期),第299-303页.
色谱指纹图谱法在参麦注射液质控中的应用;石先哲等;《色谱》;20020731;第20卷(第4期);第299-303页 *

Also Published As

Publication number Publication date
CN102435693A (en) 2012-05-02

Similar Documents

Publication Publication Date Title
CN102466658B (en) Measurement method of content of 5-hydroxymethylfurfural (5-HMF) in injection
CN111443142B (en) Method for simultaneously detecting multiple index components in Baoyuan decoction preparation
CN101638402B (en) Online quality monitoring method for salvianolic acid B production
CN102435693B (en) Method for controlling quality of midbody during preparation process of Shenmai injection
CN104777243B (en) It is a kind of at the same determine the tuber of pinellia in organic acid, nucleosides and ephedrine HPLC methods
CN101620207A (en) Quantitative measuring method for 5-hydroxymethyl furfural in shengmai injection
CN102928523A (en) Wild chrysanthemum flower fingerprint determination method, its application, and wild chrysanthemum flower quality detection method
CN105267355A (en) Extraction method of pharmaceutic preparation and building method of its prediction model
CN114487242A (en) Characteristic spectrum of endothelium corneum Gigeriae Galli and/or vinegar endothelium corneum Gigeriae Galli and its preparation, and its construction method and content determination method
CN103822975A (en) Test method for pulse-activating preparation adopting pilose asiabell root
CN103575821A (en) Detection method of 14 chemical components in Tangminling preparation
CN105510452B (en) Multi-target ingredient assay, fingerprint map construction and the preparation method of liver-benefiting eye-brightening oral liquid
CN109709222B (en) Component detection method of Ganmaoling and compound Ganmaoling
CN103940942B (en) A kind of detection method of CHANGYANNING preparation
CN101334389B (en) Morinda root oligosacchride content determination method
CN103389353A (en) Ultra-high performance liquid chromatography method for determination of content of phenolic acid components in blood-nourishing cephalocathartic particles
CN102068553B (en) Method for constructing high performance liquid chromatographic (HPLC) fingerprint of Mammary lump preparation arising from qi stagnation and blood stasis
CN105334273B (en) Detection method of anisetree bark
CN103575823A (en) Detection method of 8 chemical components in Tangminling preparation
CN113092640A (en) Method for detecting benzyl alcohol and benzaldehyde in heparin sodium injection
CN109596765B (en) Detection method of Liangfu dripping pills
CN113176366A (en) Evaluation method of secondary refined polysaccharide and flavonoid components based on spectral efficiency relationship
CN101703552B (en) Method for controlling quality of compound isatis root oral liquid
CN104458954A (en) Semen cuscutae formula particle fingerprint spectrum and building method thereof
CN100590432C (en) Method for controlling quality of zhenju hypotension preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB02 Change of applicant information

Address after: 610041, 12 Avenue, Wuhou District, Sichuan, Chengdu

Applicant after: Chuanda Huaxi Pharmaceutical Industry Co., Ltd. Sichuan Prov.

Address before: No. 26 high tech Zone Gaopeng road in Chengdu city of Sichuan Province in 610093

Applicant before: Chuanda Huaxi Pharmaceutical Industry Co., Ltd. Sichuan Prov.

C14 Grant of patent or utility model
GR01 Patent grant